Ovulation Induction

Updated: September 27, 2023

Background

Epidemiology

Anatomy

Pathophysiology

Etiology

Genetics

Prognostic Factors

Clinical History

Physical Examination

Age group

Associated comorbidity

Associated activity

Acuity of presentation

Differential Diagnoses

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

Medication

follitropin beta

Administer initial dose of 75 units daily subcutaneously or intramuscularly for minimum one week
Raise the dose by 25 or 50 units every week until adequate response as measured by follicular growth
Daily dose used during clinical trials should not exceed: 300 units
Administration
Administration of human chorionic gonadotropin (hCG) should not be given if ovaries are unusually enlarged on the last day of follitropin therapy in order to decrease the risk of developing ovarian hyperstimulation syndrome (OHSS)

menotrophin injection

150 IU IM/SC once daily in the first five days of treatment for 7-12 days
Do not exceed 450 IU once daily

Future Trends